Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design. - Muralidhar, V.; Alshalalfa, M.; Spratt, D.E.; Liu, S.; Karnes, R.J.; Schaeffer, E.M.; Davicioni, E.; Feng, F.Y.; Klein, E.A.; Tosoian, J.; Berlin, A.; Den, R.B.; et al. (International Journal of Radiation Oncology, Biology, Physics, 2020)